BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32706839)

  • 21. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.
    Knowles DM; Cesarman E
    Ann Oncol; 1997; 8 Suppl 2():123-9. PubMed ID: 9209655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi's Sarcoma Tumors during Antiretroviral Therapy.
    Nolan DJ; Rose R; Zhang R; Leong A; Fogel GB; Scholte LLS; Bethony JM; Bracci P; Lamers SL; McGrath MS
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction.
    Bobroski L; Bagasra AU; Patel D; Saikumari P; Memoli M; Abbey MV; Wood C; Sosa C; Bagasra O
    J Reprod Immunol; 1998 Dec; 41(1-2):149-60. PubMed ID: 10213307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
    Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
    Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.
    Lebari D; Gohil J; Patnaik L; Wasef W
    Int J STD AIDS; 2014 Jul; 25(8):607-10. PubMed ID: 24492851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma-associated herpes virus-derived microRNA K12-1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma.
    Huang X; Rao W; Wang C; Lu J; Li Z; Kong W; Feng Y; Xu T; Apaer R; Gao F
    SLAS Discov; 2022 Jun; 27(4):258-265. PubMed ID: 35413475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
    Dictor M; Rambech E; Way D; Witte M; Bendsöe N
    Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil.
    Ramos-da-Silva S; Elgui-de-Oliveira D; Borges L; Bacchi CE
    Braz J Med Biol Res; 2006 May; 39(5):573-80. PubMed ID: 16648893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.
    Reed JA; Nador RG; Spaulding D; Tani Y; Cesarman E; Knowles DM
    Blood; 1998 May; 91(10):3825-32. PubMed ID: 9573020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America.
    Fouchard N; Lacoste V; Couppie P; Develoux M; Mauclere P; Michel P; Herve V; Pradinaud R; Bestetti G; Huerre M; Tekaia F; de Thé G; Gessain A
    Int J Cancer; 2000 Jan; 85(2):166-70. PubMed ID: 10629072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single Nucleotide Polymorphism Analysis in HIV and Kaposi's Sarcoma Disease by Microarray Technique.
    Koyuncu I; Gönel A; Ozcan E; Temiz E; Toprak Ş; Akkafa F; Binici I
    Curr HIV Res; 2020; 18(3):154-164. PubMed ID: 32539678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication.
    Yu X; Shahir AM; Sha J; Feng Z; Eapen B; Nithianantham S; Das B; Karn J; Weinberg A; Bissada NF; Ye F
    J Virol; 2014 Apr; 88(8):4466-79. PubMed ID: 24501407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter.
    Rose TM; Bruce AG; Barcy S; Fitzgibbon M; Matsumoto LR; Ikoma M; Casper C; Orem J; Phipps W
    PLoS Pathog; 2018 Dec; 14(12):e1007441. PubMed ID: 30557332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
    Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.